{"id":23772,"date":"2024-10-18T06:37:53","date_gmt":"2024-10-18T06:37:53","guid":{"rendered":"https:\/\/www.euegeajans.com\/?p=23772"},"modified":"2024-10-18T06:37:54","modified_gmt":"2024-10-18T06:37:54","slug":"egeli-akademisyen-enflamasyonun-akciger-kanserine-etkisini-arastiracak","status":"publish","type":"post","link":"https:\/\/www.euegeajans.com\/index.php\/2024\/10\/18\/egeli-akademisyen-enflamasyonun-akciger-kanserine-etkisini-arastiracak\/","title":{"rendered":"Egeli akademisyen enflamasyonun akci\u011fer kanserine etkisini ara\u015ft\u0131racak"},"content":{"rendered":"<p style=\"font-weight: 400; text-align: justify;\"><strong>\u00a0Proje T\u00dcB\u0130TAK deste\u011fi ile ABD\u2019de y\u00fcr\u00fct\u00fclecek<\/strong><\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Ege \u00dcniversitesi Atat\u00fcrk Sa\u011fl\u0131k Hizmetleri Meslek Y\u00fcksekokulu \u00f6\u011fretim \u00fcyesi Do\u00e7. Dr. Erkan Kahraman\u2019\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131, enflamasyon ve akci\u011fer kanseri ili\u015fkisine y\u00f6nelik proje, T\u00dcB\u0130TAK taraf\u0131ndan desteklenmeye uygun bulundu. Proje ile enflamasyon ve akci\u011fer kanseri ili\u015fkisi hakk\u0131nda kritik veriler ortaya konarak akci\u011fer kanserinde enflamasyon hedefli yeni tedavi modelleri geli\u015ftirilmesi i\u00e7in temel h\u00fccresel biyolojik veriler elde edilecek.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Proje ekibini tebrik eden Rekt\u00f6r\u00a0 Prof. Dr. Necdet Budak, \u201cBilindi\u011fi gibi akci\u011fer kanseri, hem g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 hem de \u00f6l\u00fcmc\u00fcl olmas\u0131 sebebiyle ciddi bir sa\u011fl\u0131k sorunudur. Do\u00e7. Dr. Erkan Kahraman\u2019\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131 proje kapsam\u0131nda enflamasyon ve akci\u011fer kanseri aras\u0131ndaki ili\u015fki incelenecek. Sa\u011fl\u0131k alan\u0131ndaki yat\u0131r\u0131mlar\u0131m\u0131z\u0131n kar\u015f\u0131l\u0131\u011f\u0131n\u0131 ba\u015far\u0131l\u0131 projelerle almay\u0131 s\u00fcrd\u00fcr\u00fcyoruz. Hocam\u0131z\u0131 ve ekibini tebrik ediyorum\u201d diye konu\u015ftu.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Akci\u011fer kanserinin, kanser nedenli \u00f6l\u00fcmler aras\u0131nda birinci s\u0131rada yer ald\u0131\u011f\u0131n\u0131 ifade eden Do\u00e7. Dr. Erkan Kahraman, \u201cAkci\u011fer kanseri, neden oldu\u011fu komplikasyonlar ve mortalite oranlar\u0131 nedeniyle d\u00fcnya genelinde \u00fczerinde yo\u011fun \u00e7al\u0131\u015f\u0131lan, g\u00fcncel, en \u00f6nemli sa\u011fl\u0131k problemlerinin ba\u015f\u0131nda gelmektedir.<strong>\u00a0<\/strong>B\u00fct\u00fcn kanser t\u00fcrleri i\u00e7erisinde en yayg\u0131n olarak g\u00f6r\u00fclen ikinci kanser t\u00fcr\u00fc olup d\u00fcnya genelinde kanser nedenli \u00f6l\u00fcmler i\u00e7erisinde ise ilk s\u0131rada yer almaktad\u0131r. Risk fakt\u00f6rleri i\u00e7erisinde sigara kullan\u0131m\u0131, alkol, hava kirlili\u011fi, genetik yatk\u0131nl\u0131k, kronik enflamasyon, iyonizan radyasyon ve asbest, polisiklik hidrokarbonlar, a\u011f\u0131r metaller gibi maddelere mesleki ve \u00e7evresel maruziyet yer almaktad\u0131r. Akci\u011fer kanserinde geleneksel tedaviler cerrahi, radyasyon tedavisi ve kemoterapiye dayanmaktad\u0131r. Terap\u00f6tik yakla\u015f\u0131m\u0131n se\u00e7imi, kanserin tipine, hastal\u0131\u011f\u0131n evresine, hastan\u0131n fonksiyonel kabiliyetine ve hastal\u0131\u011f\u0131n genetik karakterizasyonuna ba\u011fl\u0131 olarak de\u011fi\u015fmektedir.\u00a0Kanser geli\u015fiminde hasarl\u0131 genlerin ailesel kal\u0131t\u0131m\u0131 \u00f6nemli bir yer tutmas\u0131na ra\u011fmen, asl\u0131nda\u00a0t\u00fcm kanserlerin sadece y\u00fczde 5 ila 10&#8217;u mutasyona u\u011fram\u0131\u015f genlerin ve somatik mutasyonlar\u0131n kal\u0131t\u0131m\u0131ndan kaynaklanmaktad\u0131r. Geriye kalan y\u00fczde 90 ila 95 neden ise, ya\u015fam tarz\u0131 fakt\u00f6rleri ve \u00e7evre ile ba\u011flant\u0131l\u0131 meydana gelen DNA\u2019da ortaya \u00e7\u0131kan mutajenik de\u011fi\u015fikliklerdir. \u00d6rne\u011fin,\u00a0t\u00fcm kanserlerin yakla\u015f\u0131k y\u00fczde 30&#8217;unun sigara, y\u00fczde 35&#8217;inin beslenmeyle, y\u00fczde 14 ila 20&#8217;si obeziteyle, y\u00fczde 18&#8217;inin enfeksiyonlara ve y\u00fczde 7&#8217;sinin de radyasyonla ve \u00e7evresel kirleticilerle maruziyet ile ba\u011flant\u0131l\u0131d\u0131r. T\u00fcm bu risk fakt\u00f6rlerinde ortak g\u00f6r\u00fcnen s\u00fcre\u00e7 halk aras\u0131nda iltihaplanma ya da yang\u0131 olarak da tabir edilen enflamasyondur.\u00a0Bu bulgular ve yeni geli\u015fmeler sonucu, son y\u0131llarda t\u00fcm\u00f6r ba\u015flat\u0131c\u0131 enflamasyon bir kanser belirteci olarak tan\u0131mlanm\u0131\u015ft\u0131r\u201d dedi.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\"><strong>\u201c\u00c7al\u0131\u015fmalar ABD\u2019de y\u00fcr\u00fct\u00fclecek\u201d<\/strong><\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Enflamasyonun kanser s\u00fcrecine etki etti\u011fini s\u00f6yleyen Do\u00e7. Dr. Kahraman, \u201cEnflamasyon akci\u011fer kanserinin hem ba\u015flamas\u0131nda hem de s\u00fcrd\u00fcr\u00fclmesinde kritik roller oynamaktad\u0131r. Akci\u011fer kanseri progresyonunda olu\u015fan enflamatuvar mikro\u00e7evre, ortamda bulunan immun h\u00fccreler taraf\u0131ndan sal\u0131nan bir\u00e7ok enflamatuar sitokinler nedeniyle kanser h\u00fccresinin sa\u011f kal\u0131m\u0131 ve proliferasyonu i\u00e7in avantaj sa\u011flamaktad\u0131r. Bu da kanser progresyonunun h\u0131zlanmas\u0131na hatta kemoterap\u00f6tik ila\u00e7lara kar\u015f\u0131 diren\u00e7 olu\u015fmas\u0131na yol a\u00e7maktad\u0131r. Bu nedenle enflamasyonun y\u00f6netilmesi akci\u011fer kanseri progresyonunda kritik \u00f6nem ta\u015f\u0131maktad\u0131r. Biz de yapaca\u011f\u0131m\u0131z \u00e7al\u0131\u015fma ile akci\u011fer kanseri geli\u015fimi ve ilerlemesinde kritik rolleri olan enflamasyona odaklanaca\u011f\u0131z. T\u00dcB\u0130TAK 2219 Yurt D\u0131\u015f\u0131 Doktora Sonras\u0131 Ara\u015ft\u0131rma Burs Program\u0131 deste\u011fiyle, \u00e7al\u0131\u015fmalar\u0131m\u0131 Harvard \u00dcniversitesi \u00d6\u011fretim \u00dcyesi ve Fosyth Enstit\u00fcs\u00fc Klinik Operasyonlar Direkt\u00f6r\u00fc Prof. Dr. Alpdo\u011fan Kantarc\u0131\u2019n\u0131n laboratuvar\u0131nda ve onun s\u00fcperviz\u00f6rl\u00fc\u011f\u00fcnde, Amerika Birle\u015fik Devletleri, Cambridge-Boston\u2019da 9 ay s\u00fcresince ger\u00e7ekle\u015ftirece\u011fim.\u00a0Bu zaman s\u00fcresince akci\u011fer kanseri tedavisinde enflamasyon hedefli yeni aday molek\u00fcller \u00fczerine odaklanaca\u011f\u0131z. Bir\u00e7ok ara\u015ft\u0131rma grubu ile ortak \u00e7al\u0131\u015fmalar yaparak hem akademik hem de bilimsel yeni bak\u0131\u015f a\u00e7\u0131lar\u0131 olu\u015fturmay\u0131 ama\u00e7lamaktay\u0131z.\u00a0 Ara\u015ft\u0131rma sonu\u00e7lar\u0131m\u0131z enflamasyon ve akci\u011fer kanseri ili\u015fkisi hakk\u0131nda bir\u00e7ok kritik veri ortaya koyacak, ayr\u0131ca akci\u011fer kanserinde enflamasyon hedefli yeni tedavi modelleri geli\u015ftirilmesi i\u00e7in temel h\u00fccresel biyolojik verileri sa\u011flayacakt\u0131r\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0Proje T\u00dcB\u0130TAK deste\u011fi ile ABD\u2019de y\u00fcr\u00fct\u00fclecek Ege \u00dcniversitesi Atat\u00fcrk Sa\u011fl\u0131k Hizmetleri Meslek Y\u00fcksekokulu \u00f6\u011fretim \u00fcyesi&#8230;<\/p>\n","protected":false},"author":2,"featured_media":23773,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,99,1,70,68],"tags":[],"class_list":["post-23772","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bilim","category-egitim","category-gncl","category-kampus","category-saglik"],"featured_image_urls":{"full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-scaled.jpg",2560,1707,false],"thumbnail":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-150x150.jpg",150,150,true],"medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-768x512.jpg",640,427,true],"large":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-2048x1366.jpg",2048,1366,true],"newsphere-slider-full":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-1280x720.jpg",1280,720,true],"newsphere-featured":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-1024x683.jpg",1024,683,true],"newsphere-medium":["https:\/\/www.euegeajans.com\/wp-content\/uploads\/2024\/10\/Ogr-Gor-Erkan-Kahraman-Prof.-Dr.-Necdet-Budak-720x380.jpg",720,380,true]},"author_info":{"display_name":"Editor","author_link":"https:\/\/www.euegeajans.com\/index.php\/author\/editor\/"},"category_info":"<a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/bilim\/\" rel=\"category tag\">Bilim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/egitim\/\" rel=\"category tag\">E\u011fitim<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/gncl\/\" rel=\"category tag\">G\u00fcncel<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/kampus\/\" rel=\"category tag\">Kamp\u00fcs<\/a> <a href=\"https:\/\/www.euegeajans.com\/index.php\/category\/saglik\/\" rel=\"category tag\">Sa\u011fl\u0131k<\/a>","tag_info":"Sa\u011fl\u0131k","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/23772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/comments?post=23772"}],"version-history":[{"count":1,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/23772\/revisions"}],"predecessor-version":[{"id":23774,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/posts\/23772\/revisions\/23774"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media\/23773"}],"wp:attachment":[{"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/media?parent=23772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/categories?post=23772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euegeajans.com\/index.php\/wp-json\/wp\/v2\/tags?post=23772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}